During the past decade, Precision Research Institute conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 33 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 26 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Precision Research Institute" #1 sponsor was "Bristol-Myers Squibb" with 6 trials, followed by "Shire" with 5 trials sponsored, "Celgene" with 3 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Precision Research Institute" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Premier Research Group plc" with 2 trials as a collaborator, "Algorithme Pharma Inc" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Precision Research Institute" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (5 trials), "Diabetic Gastroparesis" (4 trials), "Eosinophilic Esophagitis" (4 trials) and "Hepatitis C" (4 trials). Many other conditions were trialed in "Precision Research Institute" in a lesser frequency.

Most popular intervention types in "Precision Research Institute" are "Drug" (53 trials), "Biological" (4 trials), "Other" (4 trials), "Diagnostic Test" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Daclatasvir" (4 trials), "Ontamalimab" (4 trials), "Guselkumab Dose 1" (3 trials) and "Guselkumab Dose 2" (3 trials). Other intervention names were less common.

The vast majority of trials in "Precision Research Institute" are 60 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Precision Research Institute". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Precision Research Institute, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Precision Research Institute, 0 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".